NUNZ 0.06 Nunzia Pharmaceutical Company
| Range: | 0.003-0.694 | Vol Avg: | 2326 | Last Div: | 0 | Changes: | -0.02 |
| Beta: | -2.29 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Fri Jul 24 2009 | Empoloyees: | |||
| CUSIP: | 67097W102 | CIK: | 0000886093 | ISIN: | US67097W1027 | Country: | US |
| CEO: | Ms. Sara P. Gonzales | Website: | https://www.nunziapharma.com | ||||
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow